Four Frequently Asked Questions About Clinical Trial Participation


For patients, participating in clinical trials may potentially help researchers understand more about treating their condition. Moreover, participating in a clinical trial can frequently provide the opportunity for patients to become an integral part of support communities for their conditions.  

When signing up for studies through Leapcure, individuals can often times be quickly connected with the study coordinators at the research site nearest to them. These study coordinators offer a great understanding of the study details and specific participation requirements. They can often answer questions ranging from “What is this history of the medication involved?” to “How long will a scheduled visit take?”. 

At Leapcure, we’d like to make the participation process as transparent and comfortable as possible. Here our some of our thoughts on some of the more frequently asked questions we get from patients and patient advocacy groups:

1. What is the length of the trial? Each clinical trial differs in length, but often run from between a few weeks to a few months to multiple years. Study coordinators are typically a great resource for study length specifics to help patients figure out how to incorporate study timelines into your schedule along with guidance around the duration of the participation.

2. How many times will I need to visit the clinic? Each clinical trial visit timeline varies, typically based on a number of healthcare and research factors. Again, study coordinators can typically be a great resource for understanding how to incorporate study timelines into your schedule along with guidance around the needs for participation.

3. What are the chances I will be taking a placebo medication? Some studies will have chances of placebo and some won’t and the chances will often vary from study to study. Placebo medication can also be administered and monitored in different ways depending on the study. In some adaptive studies, there are patients that move from placebo to the treatment over time if it doesn’t significantly interfere with research objectives. In general, researchers will have a monitored placebo arm of the study in order to ensure better efficacy and safety knowledge of the treatment being researched. If you have concerns about placebo medication or how placebos are administered, it’s best to start by discussing with the study coordinator about your chances of receiving placebo as well as how your care will be managed during the study.

4. Will I be reimbursed for participation burdens? Will it cost me anything? Generally, most clinical trials will not have direct costs for participation. In many cases, there is travel reimbursement and participation reimbursement. Sometimes each clinical trial site will have their own policies for travel and participation reimbursement. We almost always suggest discussing with the study coordinator to learn about cost and reimbursement specifics. If the burden of participation combined with reimbursement/cost is prohibitive, let us know by emailing

Any other questions? You can reach out to your local site coordinator or email us at Additionally, any patient advocacy groups that would like to learn more on behalf of their patient community are also welcome to reach out to me at

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s